CytomX Therapeutics (CTMX) Files $250M Mixed Shelf

November 4, 2016 1:40 PM EDT
Get Alerts CTMX Hot Sheet
Trade CTMX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

CytomX Therapeutics (Nasdaq: CTMX) filed a registration with the U.S. SEC to sell up to $250 million of mixed securities.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Add Your Comment